Yn dangos 376 i 390 o 970 canlyniadau
Joint statement on meeting regulatory standards during periods of global or national shortage of medicines
We are concerned to hear that people with Type 2 diabetes are experiencing problems accessing GLP-1 receptor agonists (GLP-1 RAs).
Company and business names
Applying for non-objection when using protected titles in company names
Welsh Language Scheme annual monitoring report 2020
How we continue to implement steps to make sure we treat English and Welsh equally when communicating with the public in Wales
Welsh Language Scheme annual monitoring report 2019
How we continue to implement steps to make sure we treat English and Welsh equally when communicating with the public in Wales
Welsh Language Scheme annual report 2018
How we continue to implement steps to make sure we treat English and Welsh equally when communicating with the public in Wales